Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45
 

Ranbaxy Laboratories Key Financial Ratios, Ranbaxy Laboratories Financial Statement & Accounts

Ranbaxy Laboratories

BSE: 500359  |  NSE: RANBAXY  |  ISIN: INE015A01028  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Key Financial Ratios of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Investment Valuation Ratios
Face Value 10.00 5.00 5.00 5.00 5.00
Dividend Per Share 17.00 8.50 8.50 8.50 --
Operating Profit Per Share (Rs) 33.82 4.90 16.96 10.72 5.97
Net Operating Profit Per Share (Rs) 203.95 97.75 111.76 115.07 110.67
Free Reserves Per Share (Rs) 123.60 58.26 57.48 62.52 80.80
Bonus in Equity Capital 78.99 78.85 78.80 78.72 69.86
Profitability Ratios
Operating Profit Margin(%) 16.58 5.01 15.17 9.31 5.39
Profit Before Interest And Tax Margin(%) 14.31 2.21 12.52 6.52 2.03
Gross Profit Margin(%) 16.90 4.90 14.39 7.51 2.07
Cash Profit Margin(%) 15.95 8.55 11.61 17.08 16.25
Adjusted Cash Margin(%) 14.29 5.50 12.90 3.87 16.25
Net Profit Margin(%) 13.81 5.78 9.07 14.33 -22.02
Adjusted Net Profit Margin(%) 12.15 2.74 10.36 1.12 -22.02
Return On Capital Employed(%) 21.73 3.07 10.05 4.93 2.52
Return On Net Worth(%) 21.02 8.92 16.19 24.34 -29.50
Adjusted Return on Net Worth(%) 18.51 4.22 18.50 1.90 17.40
Return on Assets Excluding Revaluations 12.60 4.41 5.41 7.76 -8.70
Return on Assets Including Revaluations 12.60 4.41 5.41 7.76 -8.70
Return on Long Term Funds(%) 22.91 4.11 12.23 6.19 2.94
Liquidity And Solvency Ratios
Current Ratio 1.31 0.92 0.96 0.83 1.16
Quick Ratio 0.92 0.98 1.03 0.97 0.86
Debt Equity Ratio 0.05 0.43 1.35 1.38 1.05
Long Term Debt Equity Ratio -- 0.07 0.93 0.90 0.80
Debt Coverage Ratios
Interest Cover 52.37 3.96 9.51 3.19 1.29
Total Debt to Owners Fund 0.05 0.43 1.35 1.38 1.05
Financial Charges Coverage Ratio 59.82 7.80 11.33 4.46 2.35
Financial Charges Coverage Ratio Post Tax 56.50 12.87 9.34 8.88 -5.11
Management Efficiency Ratios
Inventory Turnover Ratio 4.26 4.11 4.39 4.42 4.07
Debtors Turnover Ratio 5.98 4.58 4.58 4.53 4.88
Investments Turnover Ratio 4.61 4.42 4.66 4.67 4.07
Fixed Assets Turnover Ratio 4.38 2.92 2.73 2.71 2.14
Total Assets Turnover Ratio 1.51 1.12 0.78 0.73 0.64
Asset Turnover Ratio 2.98 2.21 2.12 2.08 2.14
Average Raw Material Holding 135.56 119.32 112.48 99.69 121.93
Average Finished Goods Held 36.73 35.70 39.36 35.13 34.66
Number of Days In Working Capital 78.30 100.03 96.18 84.44 150.02
Profit & Loss Account Ratios
Material Cost Composition 41.32 43.05 41.01 43.35 44.05
Imported Composition of Raw Materials Consumed 54.42 54.67 55.17 51.63 51.56
Selling Distribution Cost Composition 14.00 14.73 12.98 14.01 12.84
Expenses as Composition of Total Sales 66.30 64.76 66.16 61.98 61.34
Cash Flow Indicator Ratios
Dividend Payout Ratio Net Profit 68.30 170.28 94.95 60.06 --
Dividend Payout Ratio Cash Profit 59.12 115.22 74.15 50.38 --
Earning Retention Ratio 22.38 -259.14 16.89 -668.18 --
Cash Earning Retention Ratio 34.01 -78.86 33.28 -122.14 100.00
AdjustedCash Flow Times 0.25 5.10 5.87 20.97 4.83
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Earnings Per Share 28.38 5.69 10.21 16.56 -24.85
Book Value 134.85 63.82 63.03 68.01 84.24
Source : Religare Technova
Explore Ranbaxy Labs connections